chr12-130808702-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001351052.2(STX2):c.-105A>G variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.00212 in 1,610,222 control chromosomes in the GnomAD database, including 69 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 40 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 29 hom. )
Consequence
STX2
NM_001351052.2 5_prime_UTR_premature_start_codon_gain
NM_001351052.2 5_prime_UTR_premature_start_codon_gain
Scores
1
8
9
Clinical Significance
Conservation
PhyloP100: 6.83
Genes affected
STX2 (HGNC:3403): (syntaxin 2) The product of this gene belongs to the syntaxin/epimorphin family of proteins. The syntaxins are a large protein family implicated in the targeting and fusion of intracellular transport vesicles. The product of this gene regulates epithelial-mesenchymal interactions and epithelial cell morphogenesis and activation. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006135136).
BP6
Variant 12-130808702-T-C is Benign according to our data. Variant chr12-130808702-T-C is described in ClinVar as [Benign]. Clinvar id is 714325.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0114 (1735/152354) while in subpopulation AFR AF= 0.0397 (1651/41580). AF 95% confidence interval is 0.0381. There are 40 homozygotes in gnomad4. There are 817 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 40 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STX2 | NM_194356.4 | c.283A>G | p.Ile95Val | missense_variant, splice_region_variant | 5/11 | ENST00000392373.7 | NP_919337.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STX2 | ENST00000392373.7 | c.283A>G | p.Ile95Val | missense_variant, splice_region_variant | 5/11 | 5 | NM_194356.4 | ENSP00000376178.2 |
Frequencies
GnomAD3 genomes AF: 0.0113 AC: 1720AN: 152236Hom.: 39 Cov.: 33
GnomAD3 genomes
AF:
AC:
1720
AN:
152236
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00303 AC: 750AN: 247352Hom.: 20 AF XY: 0.00233 AC XY: 311AN XY: 133450
GnomAD3 exomes
AF:
AC:
750
AN:
247352
Hom.:
AF XY:
AC XY:
311
AN XY:
133450
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00115 AC: 1671AN: 1457868Hom.: 29 Cov.: 30 AF XY: 0.00100 AC XY: 725AN XY: 725002
GnomAD4 exome
AF:
AC:
1671
AN:
1457868
Hom.:
Cov.:
30
AF XY:
AC XY:
725
AN XY:
725002
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0114 AC: 1735AN: 152354Hom.: 40 Cov.: 33 AF XY: 0.0110 AC XY: 817AN XY: 74506
GnomAD4 genome
AF:
AC:
1735
AN:
152354
Hom.:
Cov.:
33
AF XY:
AC XY:
817
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
172
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
449
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;P
Vest4
MVP
MPC
0.13
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at